Ambeed.cn

首页 / / / / Hinokiflavone/扁柏双黄酮

Hinokiflavone/扁柏双黄酮 {[allProObj[0].p_purity_real_show]}

货号:A508349 同义名: 日本扁柏黄酮

Hinokiflavone 是一种 SUMO protease 抑制剂,可抑制 sentrin 特异性蛋白酶 1 (SENP1) 的活性。Hinokiflavone 具有明显的细胞毒性,能抑制MMP-9的活性。

Hinokiflavone/扁柏双黄酮 化学结构 CAS号:19202-36-9
Hinokiflavone/扁柏双黄酮 化学结构
CAS号:19202-36-9
Hinokiflavone/扁柏双黄酮 3D分子结构
CAS号:19202-36-9
Hinokiflavone/扁柏双黄酮 化学结构 CAS号:19202-36-9
Hinokiflavone/扁柏双黄酮 3D分子结构 CAS号:19202-36-9
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Hinokiflavone/扁柏双黄酮 纯度/质量文件 产品仅供科研

货号:A508349 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

Hinokiflavone/扁柏双黄酮 生物活性

描述 Hinokiflavone, a natural product isolated and purified from the leaves of Platycladus orientalis, with significant cytotoxicity, can inhibit the activity of MMP-9.

Hinokiflavone/扁柏双黄酮 细胞实验

Cell Line
Concentration Treated Time Description References
LO2 0, 10, 20, 40, 80, 120, 160, 240, 320 µmol/L 24, 48, 72 hours HF showed much lower cytotoxicity against LO2 cells, with IC50 values of 159.1 ± 5.6 µmol/L (24 hours), 104.7 ± 4.5 µmol/L (48 hours), and 75.7 ± 2.8 µmol/L (72 hours). J Cell Mol Med. 2020 Jul;24(14):8151-8165
HepG2 0, 10, 20, 30, 40, 60, 80, 100 µmol/L 24, 48, 72 hours HF significantly inhibited the proliferation of HepG2 cells, with IC50 values of 80.8 ± 2.6 µmol/L (24 hours), 57.5 ± 5.3 µmol/L (48 hours), and 28.1 ± 2.7 µmol/L (72 hours). HF induced G0/G1 phase cell cycle arrest by up-regulating the p53/p21Cip1 signaling pathway and down-regulating G0/G1 phase-related cell cycle regulatory proteins. J Cell Mol Med. 2020 Jul;24(14):8151-8165
SMMC-7721 0, 10, 20, 30, 40, 60, 80, 100 µmol/L 24, 48, 72 hours HF significantly inhibited the proliferation of SMMC-7721 cells, with IC50 values of 74.4 ± 8.1 µmol/L (24 hours), 60.3 ± 2.9 µmol/L (48 hours), and 33.0 ± 2.6 µmol/L (72 hours). HF induced G0/G1 phase cell cycle arrest by up-regulating the p53/p21Cip1 signaling pathway and down-regulating G0/G1 phase-related cell cycle regulatory proteins. J Cell Mol Med. 2020 Jul;24(14):8151-8165
Human lung adenocarcinoma A549 cells 20 μg/mL 24 hours To measure mitochondrial membrane potential, the mitochondrial membrane potential in the HF hybrid micelles group was significantly decreased compared with that in the free HF group, indicating that HF hybrid micelles could induce mitochondria-mediated apoptosis. Drug Deliv. 2020 Dec;27(1):565-574
Human lung adenocarcinoma A549 cells 0.78 μg/mL to 50 μg/mL 24 hours To evaluate the cytotoxicity of HF hybrid micelles on A549 cells, the results showed that the IC50 value of HF hybrid micelles (7.81 μg/mL) was lower than that of free HF (19.34 μg/mL), indicating that HF hybrid micelles had higher cytotoxicity. Drug Deliv. 2020 Dec;27(1):565-574
HeLa cells 500 μM 90 minutes Inhibited splicing of Ad1 and HPV18 E6 pre-mRNAs, preventing formation of the B complex Elife. 2017 Sep 8;6:e27402
AML-2 cells 0–25 μM 24 hours Hinokiflavone attenuated the ubiquitination levels of MDM2 and p53 in AML-2 cells. Biomolecules. 2022 Apr 27;12(5):643
Klebsiella pneumoniae clinical isolates 0.25-0.5 µg/mL Evaluate the antibacterial activity of Hinokiflavone against Klebsiella pneumoniae, showing the highest antibacterial activity Pharmaceuticals (Basel). 2021 Aug 1;14(8):756
HT-29 cells 1-10 μM 24 hours To evaluate the inhibitory effect of Hinokiflavone on LPS-induced inflammatory responses, results showed that Hinokiflavone suppressed the production of IL-8 and downregulated the expression of iNOS and COX-2. Molecules. 2018 Apr 17;23(4):926
RAW 264.7 cells 1-10 μM 24 hours To evaluate the inhibitory effect of Hinokiflavone on LPS-induced inflammatory responses, results showed that Hinokiflavone suppressed the production of NO, IL-6, TNF-α, and downregulated the expression of iNOS and COX-2. Molecules. 2018 Apr 17;23(4):926
S. aureus USA300 64 μg/mL Assess the effect of Hinokiflavone on the growth of S. aureus USA300, showing no effect on bacterial growth at 64 mg/mL. Antimicrob Agents Chemother. 2022 Aug 16;66(8):e0024022
HEK293T cells 256 μg/mL 24 hours Evaluate the cytotoxicity of Hinokiflavone on HEK293T cells, showing no cytotoxicity at 256 mg/mL. Antimicrob Agents Chemother. 2022 Aug 16;66(8):e0024022
3T3-L1 cells 10 μM Assessed the effect of HF on apoptosis in differentiated 3T3-L1 cells, showing HF induced apoptosis via mitochondrial pathway J Biol Chem. 2024 Sep;300(9):107721

Hinokiflavone/扁柏双黄酮 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c-nu mice HCC xenograft model Intraperitoneal injection 4 or 8 mg/kg Every other day for ten times HF significantly inhibited the growth of HCC xenografts, with the average tumour size reduced to 831.8 mm3 and 523 mm3 in the 4 mg/kg and 8 mg/kg groups, respectively, compared to 1604 mm3 in the control group. HF up-regulated the expression levels of cleaved PARP, cleaved caspase-3, and p-JNK, and apoptosis was confirmed by TUNEL assay. J Cell Mol Med. 2020 Jul;24(14):8151-8165
BALB/c nude mice A549 xenograft tumor model Oral administration 80 mg/kg Administered on days 2, 4, 6, 8, 10, and 12, lasting for 12 days To evaluate the in vivo antitumor effect of HF hybrid micelles, the results showed that the tumor volume and weight in the HF hybrid micelles group were significantly lower than those in the free HF group and the control group, with a tumor inhibition rate of 64.76%, significantly higher than that in the free HF group (45.92%). Drug Deliv. 2020 Dec;27(1):565-574
C57BL/6J mice MRSA-induced lethal pneumonia model Subcutaneous injection 100 mg/kg/d Every 12 hours for 96 hours Evaluate the protective effect of Hinokiflavone against MRSA-induced lethal pneumonia, showing more potent than vancomycin alone when combined with vancomycin. Antimicrob Agents Chemother. 2022 Aug 16;66(8):e0024022
C57BL/6J mice High-fat diet-induced obesity model Intraperitoneal injection 5 mg/kg, 10 mg/kg, 20 mg/kg Administered every other day for 6 weeks HF suppressed obesity by inducing apoptosis in adipose tissue, improving glucose tolerance and insulin sensitivity J Biol Chem. 2024 Sep;300(9):107721

Hinokiflavone/扁柏双黄酮 参考文献

[1]Kalva S, Azhagiya Singam ER, et al. Discovery of potent inhibitor for matrix metalloproteinase-9 by pharmacophore based modeling and dynamics simulation studies. J Mol Graph Model. 2014 Apr;49:25-37.

[2]Lin YM, Chen FC, Lee KH. Hinokiflavone, a cytotoxic principle from Rhus succedanea and the cytotoxicity of the related biflavonoids. Planta Med. 1989 Apr;55(2):166-8.

Hinokiflavone/扁柏双黄酮 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.86mL

0.37mL

0.19mL

9.29mL

1.86mL

0.93mL

18.57mL

3.71mL

1.86mL

Hinokiflavone/扁柏双黄酮 技术信息

CAS号19202-36-9
分子式C30H18O10
分子量 538.46
SMILES Code O=C1C=C(C2=CC=C(O)C=C2)OC3=CC(O)=C(OC4=CC=C(C5=CC(C6=C(O)C=C(O)C=C6O5)=O)C=C4)C(O)=C13
MDL No. MFCD00017455
别名 日本扁柏黄酮
运输蓝冰
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, store in freezer, under -20°C

溶解方案

DMSO: 50 mg/mL(92.86 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

无水乙醇: 2 mg/mL(3.71 mM),配合低频超声助溶,注意:无水乙醇开封后,易挥发,也会吸收空气中的水分,导致溶解能力下降,请避免使用开封较久的乙醇

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
配制的工作液建议现用现配,短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。